Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Microbiome Syndicate is a specialized investment and strategic group focused on the rapidly evolving microbiome sector within life sciences. Often associated with Seventure Partners and its Health for Life Capital fund, the syndicate brings together a network of institutional investors, corporate partners, and scientific experts to identify and scale high-potential microbiome startups. The group provides not only capital but also deep domain expertise to companies developing live biotherapeutic products, diagnostics, and microbiome-modulating technologies. By fostering collaboration between academia and industry, the syndicate plays a pivotal role in advancing therapeutic solutions for indications ranging from inflammatory bowel disease to metabolic and oncological conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syndicate for Microbiome.